Shares of Pfizer Inc. PFE shed 1.45% to $26.52 Friday, on what proved to be an all-around grim trading session for the stock ...

The company's revenue from operations dipped 0.4% to ₹538 crore as against ₹540 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA fell ...

The work underway at the former Pfizer headquarters marks a significant addition to Gensler’s office-to-residential conversion portfolio. Its first foray into the typology was at Pearl House in the ...

The former President of Pfizer Global Manufacturing gifted $50 million to his former school, Northfield Mount Hermon.

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady cash flow.

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

There can be no greater example of Labour's naive attitude to growth and business than its refusal to back an investment on ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

The contrarian in me says that when everybody’s bullish about everything, it’s time to get a little cautious,’ says John ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...